Form 8-K - Current report:
SEC Accession No. 0001193125-24-207765
Filing Date
2024-08-27
Accepted
2024-08-27 16:08:30
Documents
13
Period of Report
2024-08-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d877676d8k.htm   iXBRL 8-K 33076
  Complete submission text file 0001193125-24-207765.txt   151873

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA me-20240826.xsd EX-101.SCH 2845
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE me-20240826_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE me-20240826_pre.xml EX-101.PRE 10811
16 EXTRACTED XBRL INSTANCE DOCUMENT d877676d8k_htm.xml XML 3561
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

EIN.: 871240344 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-39587 | Film No.: 241249062
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)